Compare JSPR & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JSPR | INTZ |
|---|---|---|
| Founded | 2018 | 1983 |
| Country | United States | United States |
| Employees | 22 | 52 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 15.7M |
| IPO Year | N/A | 2020 |
| Metric | JSPR | INTZ |
|---|---|---|
| Price | $0.47 | $0.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $15.50 | $5.75 |
| AVG Volume (30 Days) | ★ 611.9K | 136.6K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,015,000.00 |
| Revenue This Year | N/A | $25.34 |
| Revenue Next Year | N/A | $14.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.56 |
| 52 Week Low | $0.43 | $0.69 |
| 52 Week High | $7.19 | $2.64 |
| Indicator | JSPR | INTZ |
|---|---|---|
| Relative Strength Index (RSI) | 24.45 | 41.95 |
| Support Level | N/A | N/A |
| Resistance Level | $1.06 | $1.20 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 6.95 | 14.81 |
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.